Early canakinumab therapy for the sensorineural deafness in a family with Muckle-Wells syndrome due to a novel mutation of NLRP3 gene.
Iida Y, Wakiguchi H, Okazaki F, Nakamura T, Yasudo H, Kubo M, Sugahara K, Yamashita H, Suehiro Y, Okayama N, Hashimoto K, Iwamoto N, Kawakami A, Aoki Y, Takada H, Ohga S, Hasegawa S.
Iida Y, et al. Among authors: yasudo h.
Clin Rheumatol. 2019 Mar;38(3):943-948. doi: 10.1007/s10067-018-4331-8. Epub 2018 Oct 18.
Clin Rheumatol. 2019.
PMID: 30338413